Business Wire
BusinessMcDonald’s shares fall nearly 19% in six months as U.S. traffic worries investorsThe Apex TimesBusinessModerna shares jump 160%, dealing a roughly $5 billion hit to short sellersThe Apex TimesBusinessModerna and Merck tout a personalized mRNA approach that aims to train immunity against recurring melanomaThe Apex TimesBusinessTesla rises about 3% and Rivian jumps about 4%, as EV shares outperform legacy automakers after a Treasury Department noticeThe Apex TimesBusinessMSD and Moderna face a pivotal market test after Phase III melanoma data lifts hopes for a personalized cancer vaccineThe Apex TimesBusinessModerna and Merck spotlight melanoma recurrence-reduction in personalized mRNA vaccine studyThe Apex TimesBusinessPfizer tests a new angle on obesity care with berobenatide, aiming for a less-frequent optionThe Apex TimesBusinessEx–Meta child-safety engineer tells jury his family was targeted on InstagramThe Apex TimesBusinessTesla teases Cybercab launch event, raising hopes of a fresh catalyst for TSLAThe Apex TimesBusinessBerkshire’s cash pile shrank to $365.5B, and buybacks gave way to stock buying again under Greg AbelThe Apex TimesBusinessModerna and Merck move a step closer to a first mRNA cancer vaccine after a reported Phase 3 winThe Apex TimesBusinessModerna shares jump after late-stage melanoma results renew focus on its cancer pipelineThe Apex TimesBusinessMcDonald’s shares fall nearly 19% in six months as U.S. traffic worries investorsThe Apex TimesBusinessModerna shares jump 160%, dealing a roughly $5 billion hit to short sellersThe Apex TimesBusinessModerna and Merck tout a personalized mRNA approach that aims to train immunity against recurring melanomaThe Apex TimesBusinessTesla rises about 3% and Rivian jumps about 4%, as EV shares outperform legacy automakers after a Treasury Department noticeThe Apex TimesBusinessMSD and Moderna face a pivotal market test after Phase III melanoma data lifts hopes for a personalized cancer vaccineThe Apex TimesBusinessModerna and Merck spotlight melanoma recurrence-reduction in personalized mRNA vaccine studyThe Apex TimesBusinessPfizer tests a new angle on obesity care with berobenatide, aiming for a less-frequent optionThe Apex TimesBusinessEx–Meta child-safety engineer tells jury his family was targeted on InstagramThe Apex TimesBusinessTesla teases Cybercab launch event, raising hopes of a fresh catalyst for TSLAThe Apex TimesBusinessBerkshire’s cash pile shrank to $365.5B, and buybacks gave way to stock buying again under Greg AbelThe Apex TimesBusinessModerna and Merck move a step closer to a first mRNA cancer vaccine after a reported Phase 3 winThe Apex TimesBusinessModerna shares jump after late-stage melanoma results renew focus on its cancer pipelineThe Apex TimesBusinessMcDonald’s shares fall nearly 19% in six months as U.S. traffic worries investorsThe Apex TimesBusinessModerna shares jump 160%, dealing a roughly $5 billion hit to short sellersThe Apex TimesBusinessModerna and Merck tout a personalized mRNA approach that aims to train immunity against recurring melanomaThe Apex TimesBusinessTesla rises about 3% and Rivian jumps about 4%, as EV shares outperform legacy automakers after a Treasury Department noticeThe Apex TimesBusinessMSD and Moderna face a pivotal market test after Phase III melanoma data lifts hopes for a personalized cancer vaccineThe Apex TimesBusinessModerna and Merck spotlight melanoma recurrence-reduction in personalized mRNA vaccine studyThe Apex TimesBusinessPfizer tests a new angle on obesity care with berobenatide, aiming for a less-frequent optionThe Apex TimesBusinessEx–Meta child-safety engineer tells jury his family was targeted on InstagramThe Apex TimesBusinessTesla teases Cybercab launch event, raising hopes of a fresh catalyst for TSLAThe Apex TimesBusinessBerkshire’s cash pile shrank to $365.5B, and buybacks gave way to stock buying again under Greg AbelThe Apex TimesBusinessModerna and Merck move a step closer to a first mRNA cancer vaccine after a reported Phase 3 winThe Apex TimesBusinessModerna shares jump after late-stage melanoma results renew focus on its cancer pipelineThe Apex TimesBusinessMcDonald’s shares fall nearly 19% in six months as U.S. traffic worries investorsThe Apex TimesBusinessModerna shares jump 160%, dealing a roughly $5 billion hit to short sellersThe Apex TimesBusinessModerna and Merck tout a personalized mRNA approach that aims to train immunity against recurring melanomaThe Apex TimesBusinessTesla rises about 3% and Rivian jumps about 4%, as EV shares outperform legacy automakers after a Treasury Department noticeThe Apex TimesBusinessMSD and Moderna face a pivotal market test after Phase III melanoma data lifts hopes for a personalized cancer vaccineThe Apex TimesBusinessModerna and Merck spotlight melanoma recurrence-reduction in personalized mRNA vaccine studyThe Apex TimesBusinessPfizer tests a new angle on obesity care with berobenatide, aiming for a less-frequent optionThe Apex TimesBusinessEx–Meta child-safety engineer tells jury his family was targeted on InstagramThe Apex TimesBusinessTesla teases Cybercab launch event, raising hopes of a fresh catalyst for TSLAThe Apex TimesBusinessBerkshire’s cash pile shrank to $365.5B, and buybacks gave way to stock buying again under Greg AbelThe Apex TimesBusinessModerna and Merck move a step closer to a first mRNA cancer vaccine after a reported Phase 3 winThe Apex TimesBusinessModerna shares jump after late-stage melanoma results renew focus on its cancer pipelineThe Apex Times
Back to front
Disney and ABC are reportedly seeking to block the FCC’s early review of broadcast licenses
The Apex Times

THE APEX TIMES

Business/The Apex Times/Aug 19, 12:04 PM EDT

Disney and ABC are reportedly seeking to block the FCC’s early review of broadcast licenses

A report says the Walt Disney Co. and its ABC network have filed with the Federal Communications Commission to stop an expedited, early-stage look at broadcast licenses, setting up another test of how stations move through renewal and review processes.

2 min readEditor-approved Apex article

Walt Disney Co. and its ABC television network have reportedly asked the Federal Communications Commission to halt an “early review” process tied to broadcast licenses, according to a market report published Tuesday by Yahoo Finance.

The filing, as described in the report, is aimed at preventing the FCC from moving ahead with a preliminary review before the agency completes the formal steps required under its broadcast-licensing framework. Broadcast license reviews can affect the timing and conditions under which stations continue operating, and they are typically handled through agency procedures that include specific notice-and-review stages.

The report frames the dispute as a challenge to how quickly the FCC is proceeding, rather than a statement that Disney intends to abandon licenses or avoid renewal altogether. It also indicates that the FCC has responded to the request, with the response discussed in the fourth paragraph of the article.

Disney’s ABC operates broadcast television stations that hold FCC-authorized licenses. For broadcast broadcasters, license status matters not just for ongoing operations, but also for long-term planning around spectrum use, ownership and compliance obligations, and potential changes in station facilities.

A central issue in cases like this is how “early” the FCC is willing to look at compliance and licensing factors, and whether industry parties view that approach as consistent with the agency’s own procedures. The reported attempt to pause the expedited review suggests Disney and ABC believe the FCC’s schedule or method may be premature or exceed what they consider appropriate at that stage.

In broader terms, broadcast licensing is a regulated process that involves scrutiny by the FCC and, depending on the facts, can draw filings from affected parties. Even when the ultimate outcome is not immediately in doubt, procedural fights can become a lever for companies seeking more time or clearer standards before the FCC reaches certain determinations.

The report does not, in the information visible here, provide specific details such as the exact FCC docket, the legal theory for why the early review should be stopped, or what exact timeline the FCC is pursuing. It also does not describe what changes, if any, Disney and ABC would face if the early review proceeds while the dispute is pending.

What to watch next is whether the FCC formally agrees to pause the early review, and whether the agency and Disney/ABC move the dispute into a faster track or require additional briefing. The resolution could affect not only the parties named in the filing, but also how other broadcast license holders anticipate the FCC’s sequencing of renewal-related scrutiny.

Why It Matters

  • Procedural disputes over FCC review timing can affect how quickly broadcasters face potential licensing consequences.
  • If the FCC pauses the early review, it could shift leverage toward license holders seeking to keep formal review steps on a defined schedule.
  • If the FCC declines to pause, broadcasters may need to prepare for faster compliance scrutiny ahead of final determinations.
  • The outcome may influence how other broadcast entities interpret the FCC’s willingness to move at earlier stages in licensing processes.

Sources

Key Facts

  • A report says Walt Disney Co. and ABC have sought to stop an FCC “early review” of broadcast licenses.
  • The dispute is described as targeting the FCC’s timing or willingness to proceed with an expedited, preliminary stage.
  • The Yahoo Finance report indicates that the FCC responded to the request.
  • The parties involved are Disney and ABC, with ABC operating broadcast television under FCC licenses.

Media & Telecom Related